Tired-looking under eyes, dark circles, and under-eye bags can make you appear older, fatigued, and less
It activates gene expression pathways involved in collagen production, tissue regeneration, and hair follicle stimulation
Safety Considerations General Safety Profile Based on available data, both BPC-157 and TB-500 appear to demonstrate relatively favorable safety profiles, though this assessment is based on limited clinical data and long-term safety has not been evaluated through rigorous clinical trials
Common reported effects in clinical use include mild injection site reactions with subcutaneous administration, occasional digestive changes when taken orally, and rare reports of fatigue or dizziness
Carey and Pickarts ultrasound study found an average increase in collagen density of ~28% at 12 weeks, with top responders reaching 51%
An initial 4-8 week assessment period allows evaluation of individual response and tolerance before committing to extended therapy